Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication March 21, 2012
- Published online July 1, 2012.
Article Versions
- Latest version (May 15, 2012 - 04:01).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012
Author Information
- DÉSIRÉE VAN DER HEIJDE⇓,
- EDWARD C. KEYSTONE,
- JEFFREY R. CURTIS,
- ROBERT B. LANDEWÉ,
- MICHAEL H. SCHIFF,
- DINESH KHANNA,
- TORE K. KVIEN,
- LUCIAN IONESCU,
- LEON M. GERVITZ,
- OWEN R. DAVIES,
- KRISTEL LUIJTENS and
- DANIEL E. FURST
- From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Rebecca MacDonald Center for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Academic Medical Center/University of Amsterdam and Atrium Medical Center, Heerlen, The Netherlands; Rheumatology Division, University of Colorado School of Medicine, Denver, Colorado, USA; Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; UCB Pharma, Brussels, Belgium; UCB Pharma, Smyrna, Georgia, USA; and Division of Rheumatology, UCLA, Los Angeles, California, USA.
- D. van der Heijde, MD, PhD, Professor, Department of Rheumatology, Leiden University Medical Center; E.C. Keystone, MD, FRCPC, Professor of Medicine, University of Toronto; J.R. Curtis, MD, Associate Professor of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; R.B. Landewé, MD, PhD, Professor, Academic Medical Center/University of Amsterdam and Atrium Medical Center; M.H. Schiff, MD, Clinical Professor of Medicine, Rheumatology Division, University of Colorado School of Medicine; D. Khanna, MD, MS, Associate Professor of Medicine, Division of Rheumatology, University of Michigan; T.K. Kvien, MD, PhD, Professor of Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital; L. Ionescu, MD, UCB Pharma; L.M. Gervitz, PhD, UCB Pharma; O. Davies, PhD, UCB Pharma; K. Luijtens, PhD, UCB Pharma; D.E. Furst, MD, Carl M. Pearson Professor of Rheumatology, Division of Rheumatology, UCLA.
- Address correspondence to Prof. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. E-mail: d.vanderheijde{at}kpnplanet.nl
Article usage
In this issue
Timing and Magnitude of Initial Change in Disease Activity Score 28 Predicts the Likelihood of Achieving Low Disease Activity at 1 Year in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol: A Post-hoc Analysis of the RAPID 1 Trial
